We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Clinical features of delayed polyneuropathy induced by acute methamidophos toxicosis in 74 cases].
A series of 74 cases of delayed polyneuropathy induced by acute middle to serious toxicosis with Methamidophos is analysed. It consists of 49 males and 25 females aged 12 to 45 years, mean age 22.6 years. The clinical features is similar to those of acute polyneuritis in common. The determination of nerve conduction velocity and electromyography show denervation lesions. The recovery cause is from 0.5 to 2 years. The proposal of the five requirements for diagnosis is listed. It is regarded that the pathogenesis of methamidophos-induced delayed polyneuropathy is the toxic effect produced by the "aging" of the phosphoryl-enzyme complex caused by the phosphorylation of a protein neurotoxic esterase (NTE) in the nervous system, and also is the autoimmuno disorder induced by the "aging" of the NTE being probably an immunological basis.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app